SCHEMBL6428883

SCHEMBL6428883

O=C1C(Cl)=C(c2ccc(Cl)cc2)C(=O)N1Cc1cc(Cl)cc(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 3/20 0.48
NR1H3 Q13133 3/20 0.48
MAPT P10636 4/20 0.40
KDM4E B2RXH2 2/20 0.40
MAPK1 P28482 2/20 0.40
CES2 O00748 1/20 0.38
BCHE P06276 1/20 0.38
CES1 P23141 1/20 0.38
ALDH1A1 P00352 4/20 0.36
ALDH2 P05091 1/20 0.36
ALDH3A1 P30838 1/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
HPGD P15428 1/20 0.36
LMNA P02545 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6428843 0.90 NR1H2 (0.52) NR1H2NR1H3MAPTMAPK1CES2
SCHEMBL6427927 0.87 MAPT (0.52) NR1H2NR1H3MAPTKDM4EMAPK1
SCHEMBL6426484 0.84 APAF1 (0.52) NR1H2NR1H3MAPTBCHECES1
SCHEMBL6427000 0.83 NR1H2 (0.60) NR1H2NR1H3MAPTKDM4EMAPK1
SCHEMBL6426845 0.83 MAPT (0.50) NR1H2NR1H3MAPTMAPK1CES2
SCHEMBL6429547 0.80 CMA1 (0.54) NR1H2NR1H3MAPTKDM4EALDH1A1
SCHEMBL6427394 0.77 NR1H2 (0.51) NR1H2NR1H3CES2BCHECES1
SCHEMBL6426743 0.77 CMA1 (0.57) NR1H2NR1H3MAPTKDM4EMAPK1
SCHEMBL6429372 0.77 SMN1; SMN2 (0.57) MAPTKDM4EMAPK1ALDH1A1KMT2A
SCHEMBL6427708 0.76 NR1H2 (0.50) NR1H2NR1H3MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005024755-A2 MEDICAMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS OR DIABETES DECIPHERA PHARMACEUTICALS, LLC. (US) 2005-03-17 WO disclosed